Trial ID or NCT#



not recruiting iconNOT RECRUITING


Tweet2Quit is an innovative smoking cessation intervention that combines real-time online peer-to-peer support with auto messaging. In a three-group randomized controlled trial, the investigators will compare: 1) usual care, 2) Tweet2Quit-coed, and 3) Tweet2Quit-Women only.

Official Title

Social Media Technology for Treating Tobacco Addiction

Eligibility Criteria

Ages Eligible for Study: 21 Years to 59 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Yes


Judith Prochaska
Professor of Medicine (Stanford Prevention Research Center)

Contact us to find out if this trial is right for you.


Judith J Prochaska, PhD, MPH
(650) 724-3608